Tracking

Wednesday, 25 September 2019

CCC publication: A phase II trial of cabazitaxel as second line chemotherapy in relapsed locally advanced and/or metastatic carcinoma of the penis

Citation: The Journal of International Medical Research. 2019, 47(10), 4664-72 Epub 2019 Sep 10
Author: Challapalli A, Pearson S, Mitra AV, Coe M, Thomson A, Elliott T, Kirkbride P, Pickering L, Kirk H, Foulstone E, Evans H, Bravo A, Bahl AK
Abstract: KEYWORDS: Advanced penile cancer; cabazitaxel; metastasis; objective response rate; overall survival; progression-free survival; second line chemotherapy

Link to PubMed record